Get More Information on Cold Pain Therapy products Market - Request Sample Report
The Cold Pain Therapy Market Size was valued at USD 1.91 billion in 2023, and is expected to reach USD 2.96 billion by 2032, and grow at a CAGR of 5% over the forecast period 2024-2032.
The ageing population, rising healthcare costs, and rising consumer awareness of cold pain therapy products are all contributing to the significant rise of the worldwide cold pain therapy market. A rise in creative products is another factor. Releases, a surge in traffic accidents, and sport-related injuries worldwide are all contributing to the market's expansion.
Based on product, the OTC sector dominates the global market for cold pain therapy due to its accessibility, lack of a prescription from a doctor, and simplicity of usage. The availability of several pain relief solutions on the market has contributed to the popularity of cold pain therapy goods. Cold packs, rolls, cooling towels, lotions, gels, ointments, sprays, creams, and both motorised and non-motorised devices are among these items.
Products in this category include cooling towels, cold packs, rolls, lotions, gels, ointments, sprays, and both motorised and non-motorised devices. According to the application, the musculoskeletal disorders market dominates the whole world because of the rise in cases of arthritis, osteoarthritis, joint pain, and back pain. It is anticipated that the makers of items for cold pain therapy will see better growth prospects due to the emerging countries' quick expansion and technical advancements in the creation of more efficient products. The main barriers to the expansion of the worldwide market, however, are the high cost of prescription-based goods, a lack of reimbursement, and the health risks connected with the use of products for cold treatment.
DRIVERS
Rising Prevalence of Musculoskeletal Disorders
Increasing Awareness of Non-Pharmacological Pain Relief
RESTRAIN
Increasing competition from other non-invasive pain management therapies like heat therapy and TENS
OPPORTUNITY
Increasing development of smart cold therapy devices with features like temperature control, compression, and app connectivity
Increasing adoption of analgesic patches
A transdermal drug delivery system, which is a minimally intrusive method of administering medication via the skin, is included in analgesic patches. When applied to the skin, patches disperse analgesic medication over the dermis at a constant rate. Applying painkiller patches Compared to oral drugs, transdermal drug delivery methods provide a number of benefits.
CHALLENGES
Rise of counterfeit or substandard cold therapy products
Tariffs and Trade Barriers Trade restrictions and taxes on products and services between contending nations and their trading partners might come from geopolitical conflicts. These trade restrictions may limit the export and import of goods used in cold pain treatment, limiting their accessibility to markets and supply. Healthcare Infrastructure Challenges The continuous fighting may strain the region's healthcare system, taking resources and attention away from less urgent medical requirements like the use of cold pain treatment. Change in the Patient Population Conflict can cause migration and population displacement, which might alter patient demographics. This may affect the need for medical supplies, such as equipment for cold pain management, in both the afflicted areas and places where displaced people seek safety.
IMPACT OF ONGOING RECESSION
Consumers and healthcare professionals may become more price-sensitive during economic downturns and look for cheaper solutions for medical items, such as cold pain treatment devices. Product Innovation and Value-Driven Design Recessions can spur innovation as businesses work to provide more affordable and value-driven cold pain treatment goods to appeal to a price-sensitive consumer. Changes in employment and insurance policies during a downturn may affect patients' access to medical care and treatments, such as cold pain therapy. Public healthcare During recessions, spending on government healthcare programmes may be limited. This may have an impact on financing and reimbursement plans for medical equipment, which may have an impact on the uptake of goods for cold pain management.
Economic downturns can affect the supply chains for medical equipment, particularly those used in cold pain treatment, which could result in shortages or delayed availability.
By Product
OTC Products
Gels, Ointments, & Creams
Sprays & Foams
Patches
Roll-Ons
Cold Packs
Others
Prescription Products
Motorized Devices
Non-motorized Devices
By Application
Orthopedic Conditions
Post-operative Therapy
Post-trauma Therapy
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
E-Commerce
North America dominated the cold pain therapy market in 2023. In this region, a significant portion of the population suffers from conditions like arthritis or back pain, which cold therapy can effectively manage. The aging population, prone to chronic pain, also finds relief in cold therapy. The region's active lifestyle and sports culture lead to a high number of injuries, making cold therapy a popular recovery tool. For instance, in 2021, Breg, Inc. introduced the Polar Care Cube, a high-tech cold therapy system specifically designed for post-surgery pain relief. The growing popularity of cold therapy is further highlighted by its increasing use in professional sports leagues, where athletes utilize it for pain management and injury recovery.
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Get Customized Report as per Your Business Requirement - Request For Customized Report
Key Players
The major players are Beiersdorf AG, DJO Global, Inc, Hisamitsu Pharmaceutical Co., Inc., Ossur, Johnson & Johnson, Pfizer, Sanofi, Rohto Pharmaceutical, 3M, Cardinal Health Inc., Bird & Cronin, Compass Health Brands, Breg, Inc., Medline Industrie, Performance Health, Romsons Group of Industries, Unexo Life Sciences, Polar Products, Rapid Aid, Mueller Sports Medicines, Pic Solution, Bruder Healthcare Company, Brownmed Inc., Medichill, and others.
Food and Drug Administration: April 2022, Enjaymo (sutimlimab-jome) infusion was given the go-ahead by the Food and Drug Administration to help individuals with cold agglutinin disease (CAD) avoid the requirement for blood transfusions caused by hemolysis (red blood cell breakdown).
Zixa: April 2022, Innovative oil-in-water FlashMicelle Technology with a dual-action formulation was introduced by Zixa Strong for quick relief from severe pain.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.91 Bn |
| Market Size by 2032 | US$ 2.96 Bn |
| CAGR | CAGR of 5% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (OTC Products, Gels, Ointments, & Creams, Sprays & Foams, Patches) • By Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine, Post-trauma Therapy) • By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Beiersdorf AG, DJO Global, Inc, Hisamitsu Pharmaceutical Co., Inc., Ossur, Johnson & Johnson, Pfizer, Sanofi, Rohto Pharmaceutical, 3M, Cardinal Health Inc., Bird & Cronin, Compass Health Brands, Breg, Inc., Medline Industrie, Performance Health, Romsons Group of Industries, Unexo Life Sciences, Polar Products, Rapid Aid, Mueller Sports Medicines, Pic Solution, Bruder Healthcare Company, Brownmed Inc., Medichill |
| Key Drivers | • Increasing usage of inexpensive painkillers for quick relief. |
| Market Restraints | • Ibuprofen, aspirin, and paracetamol, or acetaminophen, are the three most commonly used OTC analgesic medications |
Ans: The Cold Pain Therapy Market is expected to grow at a 5% CAGR from 2024 to 2032.
Ans: According to our analysis, the Cold Pain Therapy Market is anticipated to reach USD 2.96 billion by 2032.
Ans: The prominent players in the Cold Pain Therapy Market are Beiersdorf AG, DJO Global, Inc, Hisamitsu Pharmaceutical Co., Inc., Ossur, Johnson & Johnson, Pfizer, Sanofi, Rohto Pharmaceutical, 3M, Cardinal Health Inc., and others.
Ans: The market is expanding as a consequence of several important causes, such as the increased frequency of orthopaedic illnesses, the rise in sports injuries, the ageing population, and the rise in traumatic injuries from slips, trips, and falls, as well as accidents on the road.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Cold Pain Therapy, By Product
8.1 OTC Products
8.2 Gels, Ointments, & Creams
8.3 Sprays & Foams
8.4 Patches
8.5 Roll-Ons
8.6 Cold Packs
8.7 Others
8.8 Prescription Products
8.9 Motorized Devices
8.10 Non-motorized Devices
9. Cold Pain Therapy, By Application
9.1 Orthopedic Conditions
9.2 Post-operative Therapy
9.3 Sports Medicine
9.4 Post-trauma Therapy
10. Cold Pain Therapy, By Distribution Channel
10.1 Hospital Pharmacy
10.2 Retail Pharmacy
10.3 E-Commerce
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Cold Pain Therapy by Country
11.2.2North America Cold Pain Therapy by Product
11.2.3 North America Cold Pain Therapy by Application
11.2.4 North America Cold Pain Therapy by Distribution Channel
11.2.5 USA
11.2.5.1 USA Cold Pain Therapy by Product
11.2.5.2 USA Cold Pain Therapy by Application
11.2.5.3 USA Cold Pain Therapy by Distribution Channel
11.2.6 Canada
11.2.6.1 Canada Cold Pain Therapy by Product
11.2.6.2 Canada Cold Pain Therapy by Application
11.2.6.3 Canada Cold Pain Therapy by Distribution Channel
11.2.7 Mexico
11.2.7.1 Mexico Cold Pain Therapy by Product
11.2.7.2 Mexico Cold Pain Therapy by Application
11.2.7.3 Mexico Cold Pain Therapy by Distribution Channel
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Cold Pain Therapy by Country
11.3.1.2 Eastern Europe Cold Pain Therapy by Product
11.3.1.3 Eastern Europe Cold Pain Therapy by Application
11.3.1.4 Eastern Europe Cold Pain Therapy by Distribution Channel
11.3.1.5 Poland
11.3.1.5.1 Poland Cold Pain Therapy by Product
11.3.1.5.2 Poland Cold Pain Therapy by Application
11.3.1.5.3 Poland Cold Pain Therapy by Distribution Channel
11.3.1.6 Romania
11.3.1.6.1 Romania Cold Pain Therapy by Product
11.3.1.6.2 Romania Cold Pain Therapy by Application
11.3.1.6.4 Romania Cold Pain Therapy by Distribution Channel
11.3.1.7 Turkey
11.3.1.7.1 Turkey Cold Pain Therapy by Product
11.3.1.7.2 Turkey Cold Pain Therapy by Application
11.3.1.7.3 Turkey Cold Pain Therapy by Distribution Channel
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Cold Pain Therapy by Product
11.3.1.8.2 Rest of Eastern Europe Cold Pain Therapy by Application
11.3.1.8.3 Rest of Eastern Europe Cold Pain Therapy by Distribution Channel
11.3.2 Western Europe
11.3.2.1 Western Europe Cold Pain Therapy by Product
11.3.2.2 Western Europe Cold Pain Therapy by Application
11.3.2.3 Western Europe Cold Pain Therapy by Distribution Channel
11.3.2.4 Germany
11.3.2.4.1 Germany Cold Pain Therapy by Product
11.3.2.4.2 Germany Cold Pain Therapy by Application
11.3.2.4.3 Germany Cold Pain Therapy by Distribution Channel
11.3.2.5 France
11.3.2.5.1 France Cold Pain Therapy by Product
11.3.2.5.2 France Cold Pain Therapy by Application
11.3.2.5.3 France Cold Pain Therapy by Distribution Channel
11.3.2.6 UK
11.3.2.6.1 UK Cold Pain Therapy by Product
11.3.2.6.2 UK Cold Pain Therapy by Application
11.3.2.6.3 UK Cold Pain Therapy by Distribution Channel
11.3.2.7 Italy
11.3.2.7.1 Italy Cold Pain Therapy by Product
11.3.2.7.2 Italy Cold Pain Therapy by Application
11.3.2.7.3 Italy Cold Pain Therapy by Distribution Channel
11.3.2.8 Spain
11.3.2.8.1 Spain Cold Pain Therapy by Product
11.3.2.8.2 Spain Cold Pain Therapy by Application
11.3.2.8.3 Spain Cold Pain Therapy by Distribution Channel
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Cold Pain Therapy by Product
11.3.2.9.2 Netherlands Cold Pain Therapy by Application
11.3.2.9.3 Netherlands Cold Pain Therapy by Distribution Channel
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Cold Pain Therapy by Product
11.3.2.10.2 Switzerland Cold Pain Therapy by Application
11.3.2.10.3 Switzerland Cold Pain Therapy by Distribution Channel
11.3.2.11.1 Austria
11.3.2.11.2 Austria Cold Pain Therapy by Product
11.3.2.11.3 Austria Cold Pain Therapy by Application
11.3.2.11.4 Austria Cold Pain Therapy by Distribution Channel
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Cold Pain Therapy by Product
11.3.2.12.2 Rest of Western Europe Cold Pain Therapy by Application
11.3.2.12.3 Rest of Western Europe Cold Pain Therapy by Distribution Channel
11.4 Asia-Pacific
11.4.1 Asia-Pacific Cold Pain Therapy by Country
11.4.2 Asia-Pacific Cold Pain Therapy by Product
11.4.3 Asia-Pacific Cold Pain Therapy by Application
11.4.4 Asia-Pacific Cold Pain Therapy by Distribution Channel
11.4.5 China
11.4.5.1 China Cold Pain Therapy by Product
11.4.5.2 China Cold Pain Therapy by Application
11.4.5.3 China Cold Pain Therapy Distribution Channel
11.4.6 India
11.4.6.1 India Cold Pain Therapy by Product
11.4.6.2 India Cold Pain Therapy by Application
11.4.6.3 India Cold Pain Therapy by Distribution Channel
11.4.7 Japan
11.4.7.1 Japan Cold Pain Therapy by Product
11.4.7.2 Japan Cold Pain Therapy by Application
11.4.7.3 Japan Cold Pain Therapy by Distribution Channel
11.4.8 South Korea
11.4.8.1 South Korea Cold Pain Therapy by Product
11.4.8.2 South Korea Cold Pain Therapy by Application
11.4.8.3 South Korea Cold Pain Therapy by Distribution Channel
11.4.9 Vietnam
11.4.9.1 Vietnam Cold Pain Therapy by Product
11.4.9.2 Vietnam Cold Pain Therapy by Application
11.4.9.3 Vietnam Cold Pain Therapy by Distribution Channel
11.4.10 Singapore
11.4.10.1 Singapore Cold Pain Therapy by Product
11.4.10.2 Singapore Cold Pain Therapy by Application
11.4.10.3 Singapore Cold Pain Therapy by Distribution Channel
11.4.11 Australia
11.4.11.1 Australia Cold Pain Therapy by Product
11.4.11.2 Australia Cold Pain Therapy by Application
11.4.11.3 Australia Cold Pain Therapy by Distribution Channel
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Cold Pain Therapy by Product
11.4.12.2 Rest of Asia-Pacific Cold Pain Therapy by Application
11.4.12.3 Rest of Asia-Pacific Cold Pain Therapy by Distribution Channel
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Cold Pain Therapy by Country
11.5.1.2 Middle East Cold Pain Therapy by Product
11.5.1.3 Middle East Cold Pain Therapy by Application
11.5.1.4 Middle East Cold Pain Therapy by Distribution Channel
11.5.1.5 UAE
11.5.1.5.1 UAE Cold Pain Therapy by Product
11.5.1.5.2 UAE Cold Pain Therapy by Application
11.5.1.5.3 UAE Cold Pain Therapy by Distribution Channel
11.5.1.6 Egypt
11.5.1.6.1 Egypt Cold Pain Therapy by Product
11.5.1.6.2 Egypt Cold Pain Therapy by Application
11.5.1.6.3 Egypt Cold Pain Therapy by Distribution Channel
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Cold Pain Therapy by Product
11.5.1.7.2 Saudi Arabia Cold Pain Therapy by Application
11.5.1.7.3 Saudi Arabia Cold Pain Therapy by Distribution Channel
11.5.1.8 Qatar
11.5.1.8.1 Qatar Cold Pain Therapy by Product
11.5.1.8.2 Qatar Cold Pain Therapy by Application
11.5.1.8.3 Qatar Cold Pain Therapy by Distribution Channel
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Cold Pain Therapy by Product
11.5.1.9.2 Rest of Middle East Cold Pain Therapy by Application
11.5.1.9.3 Rest of Middle East Cold Pain Therapy by Distribution Channel
11.5.2 Africa
11.5.2.1 Africa Cold Pain Therapy by Country
11.5.2.2 Africa Cold Pain Therapy by Product
11.5.2.3 Africa Cold Pain Therapy by Application
11.5.2.4 Africa Cold Pain Therapy by Distribution Channel
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Cold Pain Therapy by Product
11.5.2.5.2 Nigeria Cold Pain Therapy by Application
11.5.2.5.3 Nigeria Cold Pain Therapy by Distribution Channel
11.5.2.6 South Africa
11.5.2.6.1 South Africa Cold Pain Therapy by Product
11.5.2.6.2 South Africa Cold Pain Therapy by Application
11.5.2.6.3 South Africa Cold Pain Therapy by Distribution Channel
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Cold Pain Therapy by Product
11.5.2.7.2 Rest of Africa Cold Pain Therapy by Application
11.5.2.7.3 Rest of Africa Cold Pain Therapy by Distribution Channel
11.6 Latin America
11.6.1 Latin America Cold Pain Therapy by Country
11.6.2 Latin America Cold Pain Therapy by Product
11.6.3 Latin America Cold Pain Therapy by Application
11.6.4 Latin America Cold Pain Therapy by Distribution Channel
11.6.5 Brazil
11.6.5.1 Brazil America Wheelchair by Product
11.6.5.2 Brazil America Wheelchair by Application
11.6.5.3 Brazil America Wheelchair by Distribution Channel
11.6.6 Argentina
11.6.6.1 Argentina America Wheelchair by Product
11.6.6.2 Argentina America Wheelchair by Application
11.6.6.3 Argentina America Wheelchair by Distribution Channel
11.6.7 Colombia
11.6.7.1 Colombia America Wheelchair by Product
11.6.7.2 Colombia America Wheelchair by Application
11.6.7.3 Colombia America Wheelchair by Distribution Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Wheelchair by Product
11.6.8.2 Rest of Latin America Wheelchair by Application
11.6.8.3 Rest of Latin America Wheelchair by Distribution Channel
12. Company profile
12.1 Beiersdorf AG.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 DJO Global, Inc.
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Hisamitsu Pharmaceutical Co., Inc.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Ossur.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Johnson & Johnson.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Pfizer.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Sanofi.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Rohto Pharmaceutical.
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 3M.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Cardinal Health Inc.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Dermatology Devices Market Size was valued at USD 8.94 billion in 2023, and is expected to reach USD 21.06 billion by 2031, and grow at a CAGR of 11.92% over the forecast period 2024-2031.
The Biohacking Market size was valued at USD 23.5 billion in 2023 and is expected to reach USD 97.07 billion by 2031 and grow at a CAGR of 19.4% over the forecast period of 2024-2031.
The Growth hormone deficiency market Size was valued at USD 5.4 billion in 2023 and is expected to reach USD 8.5 billion by 2032 and grow at a CAGR of 5.0% over the forecast period 2024-2032.
The Proteomics Market Size was valued at USD 30.61 billion in 2023 and is expected to reach USD 96.35 Billion by 2032, growing at a CAGR of 13.61% from 2024-2032.
The Respiratory Syncytial Virus Therapeutics Market size was USD 1.37 Bn in 2023 & will reach USD 4.05 Bn by 2031 & grow at a CAGR of 14.5% by 2024-2031.
The Military Wearable Medical Device Market Size was valued at USD 7.84 billion in 2023 and is expected to reach USD 64.47 billion by 2032, and grow at a CAGR of 26.40% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
